Imaging Informatics Provider Announces FDA Clearance of New Platform
By MedImaging International staff writers Posted on 08 Sep 2015 |
A new clinical decision support platform for enterprise Picture Archiving and Communication System (PACS) and Vendor Neutral Archives (VNA) has received US Food and Drug Administration (FDA) 510 (k) clearance.
The platform was designed to integrate and align with enterprise PACS and VNA systems using industry-standard formats such as the US American College of Radiology (ACR) Imaging 3.0 initiative.
The platform was developed by HealthMyne (Madison, WI, USA), an imaging informatics company, and is intended to help radiologists provide diagnostic imaging data to clinicians before and after performing an imaging exam during the clinical workflow.
HealthMyne’s image data mining platforms can help radiologist and oncologists increase their workflow efficiency by automating data capture, and structured reports. The platform will provide integrated patient progression timelines, and analytics and enable clinicians to compare data for an individual patient with a patient cohort. HealthMyne’s analytic tools are also intended to help researchers explore quantitative imaging biomarkers, and support improved clinical trials of innovative therapies.
Praveen Sinha, CEO of HealthMyne, said, “Having a strong diagnostic imaging platform cleared by the FDA is the first step in our vision of bringing imaging informatics to mainstream healthcare. Significant achievements are being realized elsewhere through clinical data aggregation and analysis, yet imaging has gone largely untapped. As an example, the potential impact of streamlined patient cohort comparison on personalized medicine is truly exciting.”
Related Links:
HealthMyne
The platform was designed to integrate and align with enterprise PACS and VNA systems using industry-standard formats such as the US American College of Radiology (ACR) Imaging 3.0 initiative.
The platform was developed by HealthMyne (Madison, WI, USA), an imaging informatics company, and is intended to help radiologists provide diagnostic imaging data to clinicians before and after performing an imaging exam during the clinical workflow.
HealthMyne’s image data mining platforms can help radiologist and oncologists increase their workflow efficiency by automating data capture, and structured reports. The platform will provide integrated patient progression timelines, and analytics and enable clinicians to compare data for an individual patient with a patient cohort. HealthMyne’s analytic tools are also intended to help researchers explore quantitative imaging biomarkers, and support improved clinical trials of innovative therapies.
Praveen Sinha, CEO of HealthMyne, said, “Having a strong diagnostic imaging platform cleared by the FDA is the first step in our vision of bringing imaging informatics to mainstream healthcare. Significant achievements are being realized elsewhere through clinical data aggregation and analysis, yet imaging has gone largely untapped. As an example, the potential impact of streamlined patient cohort comparison on personalized medicine is truly exciting.”
Related Links:
HealthMyne
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow
Channels
Radiography
view channel
AI Helps Radiologists Spot More Lesions in Mammograms
Breast cancer is a critical health issue, and accurate detection through mammography is essential for effective treatment. However, interpreting mammograms can be challenging for radiologists, particularly... Read more
AI Detects Fatty Liver Disease from Chest X-Rays
Fatty liver disease, which results from excess fat accumulation in the liver, is believed to impact approximately one in four individuals globally. If not addressed in time, it can progress to severe conditions... Read moreMRI
view channel
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read more
New MRI Technique Reveals Hidden Heart Issues
Traditional exercise stress tests conducted within an MRI machine require patients to lie flat, a position that artificially improves heart function by increasing stroke volume due to gravity-driven blood... Read moreUltrasound
view channel
Pain-Free Breast Imaging System Performs One Minute Cancer Scan
Breast cancer is one of the leading causes of death for women worldwide, and early detection is key to improving outcomes. Traditional methods like mammograms and ultrasound have their limitations, particularly... Read more
Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery
Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read moreNuclear Medicine
view channel
Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more
New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
Prostate cancer is the second leading cause of cancer-related death among men in the United States. However, the majority of older men diagnosed with prostate cancer have slow-growing, low-risk forms of... Read moreGeneral/Advanced Imaging
view channel
CT Colonography Beats Stool DNA Testing for Colon Cancer Screening
As colorectal cancer remains the second leading cause of cancer-related deaths worldwide, early detection through screening is vital to reduce advanced-stage treatments and associated costs.... Read more
First-Of-Its-Kind Wearable Device Offers Revolutionary Alternative to CT Scans
Currently, patients with conditions such as heart failure, pneumonia, or respiratory distress often require multiple imaging procedures that are intermittent, disruptive, and involve high levels of radiation.... Read more
AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
Radioligand therapy, a form of targeted nuclear medicine, has recently gained attention for its potential in treating specific types of tumors. However, one of the potential side effects of this therapy... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more